Asian Liver Disease
    
  
      Clinical Trials
  
            Find your care
      
    
          We care for patients with a language-sensitive and culturally conscious approach. Call 310-794-7788 to learn more about the Asian Liver Program at UCLA Health.
Clinical Trials in: Acute Liver Failure
- 
	
A Multicenter Therapy Trial for Acute Liver Failure
- Eligibility - Fulminant liver failure of any cause
 - Treatment - This is an NIH observational study
 - Principal Investigator - Steven Huy-Han, M.D.
 - Contact - Val Peacock, RN (310) 794-6067
 
 - 
	
A Phase IV, 2x2 Factorial, Double-Blind Design of 24 Versus 48 Weeks and 90 Versus 180 mcg Doses of Pegylated Interferon Alfa-2A 40 KD (Peg-IFN, RO 25-8310) in Adult Patients with HBEAG Positive Chronic Hepatitis B"
- Eligibility - Chronic hepatits B patients, HBe(+), elevated ALT levels
 - Treatment - Pegylated interferon -alfa-2a
 - Principal Investigator - Steven Huy-Han, M.D.
 - Contact - Val Peacock, RN - (310) 794-6067
 
 
For More Information on clinical trials at UCLA: UCLA Clinical Trials